Pasithea Therapeutics Corp. (KTTA) Earnings
Pasithea Therapeutics Corp.'s most recently reported earnings, recent earnings filings (8-K) and headline annual financials, sourced from SEC EDGAR.
Last reported earnings
Not available
From the latest earnings 8-K
Revenue • FY2025
$0
As reported
Diluted EPS • FY2025
$-2.91
▲ 77.1%YoY
Reported earnings dates are based on the latest 8-K (Item 2.02) filings. The next earnings date is an estimate projected from KTTA's historical reporting pattern, not a company-confirmed date.
Headline financials
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $0 | -$20.43M | — | $-2.91 | — | — | — |
| FY2024 | $0 | -$13.9M | — | $-12.69 | — | — | — |
| FY2023 | $0 | -$15.96M | — | $-0.42 | -$12.85M | — | -100.0% |
| FY2022 | $486.6K | -$13.94M | $373.4K | $-0.53 | -$14.94M | -3045.1% | +3130.4% |
Recent earnings filings
No earnings filings are available yet.
Never miss a KTTA filing.
Get an email when KTTA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Oct 17, 2026Source: SEC EDGAR.